Skip to results
Modify your search
NARROW
1-13 of 13
Authors: Isabelle Aerts
Journal Article
Assessment of Puberty and Hypothalamic–Pituitary–Gonadal Axis Function After Childhood Brain Tumor Treatment
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 9, September 2023, Pages e823–e831, https://doi.org/10.1210/clinem/dgad097
Published: 22 February 2023
Journal Article
High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 5, May 2022, Pages e2156–e2166, https://doi.org/10.1210/clinem/dgab893
Published: 16 December 2021
Journal Article
EPCT-11. PHASE 1 STUDY OF FLUVASTATIN-CELECOXIB COMBINATION IN CHILDREN WITH RELAPSING/REFRACTORY OPTICO-CHIASMATIC LOW-GRADE GLIOMA OR HIGH-GRADE GLIOMAS (FLUVABREX): FINAL RESULTS
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii305–iii306, https://doi.org/10.1093/neuonc/noaa222.134
Published: 04 December 2020
Journal Article
LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG)
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii375, https://doi.org/10.1093/neuonc/noaa222.427
Published: 04 December 2020
Journal Article
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa075, https://doi.org/10.1093/noajnl/vdaa075
Published: 09 June 2020
Journal Article
LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i114, https://doi.org/10.1093/neuonc/noy059.387
Published: 22 June 2018
Journal Article
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Neuro-Oncology, Volume 19, Issue 11, November 2017, Pages 1542–1552, https://doi.org/10.1093/neuonc/nox109
Published: 09 June 2017
Journal Article
EPT-07PARTICIPATION OF CHILDREN AND ADOLESCENTS WITH CENTRAL NERVOUS SYSTEM TUMOURS IN PHASE I TRIALS WITHIN THE ITCC EUROPEAN CONSORTIUM
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii25, https://doi.org/10.1093/neuonc/now069.06
Published: 30 May 2016
Journal Article
EPT-13RAPIRI I – PHASE I STUDY OF DAILY ORAL RAPAMYCIN AND INTRAVENOUS IRINOTECAN IN CHILDREN WITH A RECURRENT/REFRACTORY MALIGNANT SOLID TUMOR: GOOD TOLERANCE AND PROMISING RESULTS IN BRAIN TUMORS - A REPORT FROM THE SOCIÉTÉ FRANÇAISE DES CANCERS ET LEUCÉMIES DE L'ENFANT ET DE L'ADOLESCENT (SFCE)
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii26, https://doi.org/10.1093/neuonc/now069.12
Published: 30 May 2016
Journal Article
The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion Get access
Human Molecular Genetics, Volume 23, Issue 19, 1 October 2014, Pages 5243–5250, https://doi.org/10.1093/hmg/ddu245
Published: 23 May 2014
Journal Article
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study Get access
Neuro-Oncology, Volume 15, Issue 9, September 2013, Pages 1236–1243, https://doi.org/10.1093/neuonc/not097
Published: 14 July 2013
Journal Article
MDM2 as a Modifier Gene in Retinoblastoma Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 23, 1 December 2010, Pages 1805–1808, https://doi.org/10.1093/jnci/djq416
Published: 04 November 2010
Journal Article
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors Get access
Neuro-Oncology, Volume 13, Issue 1, January 2011, Pages 109–118, https://doi.org/10.1093/neuonc/noq141
Published: 25 October 2010
